1. Руководство по гематологии в 3 томах / Под ред. А. И. Воробьева. — М.: Нью-диамед, 2005.
2. Laffan MA, Lester W, O'Donnell JS et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014; 167:453—465.
3. Sadler JE, Budde U, Eikenboom JC et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb Haemost 2006; 4:2103—2114.
4. Burtis CA, Ashwood ER, Bruns DE (eds). Tietz fundamentals of clinical chemistry. 6th ed. St. Louis: Saunders Elsevier; 2007.
5. Основы клинической гемостазиологии и гемореологии: монография / Под ред. И. Л. Давыдкина, А. П. Момота, Н. И. Зозули, Е. В. Ройтмана. — Самара: ООО ИПК «Самарская Губерния», 2017.
6. Federici AB, Bucciarelli P, Castaman G et al. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood 2014; 23:4037—4044.
7. De Wee EM, Frank WG, Leebeek FWG et al. Diagnosis and Management of Von Willebrand Disease in The Netherlands. Semin Thromb Hemost 2011; 37: 480—448.
8. Budde U, Pieconka A, Will K et al. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification. Semin Thromb Hemost 2006; 32:515—521.
9. Момот А. П. Принципы и алгоритмы клинико-лабораторной диагностики. — СПб: ФормаТ, 2006.
10. Castaman G, Linari S. Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. J Clin Med 2017; 6:45.
11. Lillicrap D. Von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood 2013; 122:3735—3740.
12. Quiroga T, Goycoolea M, Belmont S et al. Quantitative impact of using different criteria for the laboratory diagnosis of type 1 VWD. J Thromb Haemost 2014; 12: 1238— 1243.
13. Баркаган З. С., Момот А. П. Диагностика и контролируемая терапия нарушений гемостаза. — М.: Ньюдиамид, 2001.
14. Favaloro EJ, Bonar RA, Meiring M et al. Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb Res 2014; 134: 393—40310
15. Tosetto A, Castaman G, Plug I et al. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 2011; 9:1143—1148.
16. Brown DL. Congenital bleeding disorders. Curr Probl Pediatr Health Care 2005; 35:38—62.
17. Abshire TC. Prophylaxis and von Willebrand’s disease (VWD). Thromb Res 2006; 118:S3—S7.
18. Van Schie MC, Wieberdink RG, Koudstaal PJ et al. Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study. J Thromb Haemost 2012; 10:550—556.
19. Lassila R, Holme PA, Landorph A et al. Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease. Semin Thromb Hemost 2011; 37:495—502.
20. Mannucci PM. Treatment of von Willebrand’s disease. N Engl J Med 2004; 351:683— 694.
21. Paul LF, Giangrande PLF. Pregnancy in women with inherited bleeding disorders. World Federation of Haemophilia. Treatment of Hemophilia 2003; 29:9.
22. Caleizi C, Tsakiris DA, Behringer H et al. Two consecutive pregnancies and deliveries in patients with von Willebrand disease type 3. Haemophilia 1998; 4:845—849.
23. Scharrer I. Women with von Willebrand disease. Haemostasiologie 2004; 24:44— 49.
24. Шабалов Н. П. Гемостаз в динамике первой недели жизни как отражение механизмов адаптации к внеутробной жизни новорожденных. Педиатрия 2000; 3:84— 91.